Cargando…
The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases
Phosphodiesterase inhibitors (PDE) can be used as therapeutic agents for various diseases such as dementia, depression, schizophrenia and erectile dysfunction in men, as well as congestive heart failure, chronic obstructive pulmonary disease, rheumatoid arthritis, other inflammatory diseases, diabet...
Autor principal: | Butrous, Ghazwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bloomsbury Qatar Foundation Journals
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352681/ https://www.ncbi.nlm.nih.gov/pubmed/25780785 http://dx.doi.org/10.5339/gcsp.2014.42 |
Ejemplares similares
-
Saudi guidelines on the treatment and management of pulmonary hypertension 2014: Updates a fresh understanding of pulmonary vascular diseases in the developing world
por: Butrous, Ghazwan
Publicado: (2014) -
Role of prostacyclin in pulmonary hypertension
por: Mitchell, Jane A., et al.
Publicado: (2014) -
Progress in the understanding and management of pulmonary arterial hypertension
por: Chakrabarti, A.M., et al.
Publicado: (2015) -
Infection in pulmonary vascular diseases: Would another consortium really be the way to go?
por: Butrous, Ghazwan, et al.
Publicado: (2019) -
The world of pulmonary vascular disease
por: Yuan, Jason X.-J., et al.
Publicado: (2011)